Unfavorable efficacy to (131)I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb

por Zhang, Na, Liang, Jun, Lin, Yan-Song
Publicado 2017

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer

por Mu, Zhuan-Zhuan, Zhang, Xin, Lin, Yan-Song
Publicado 2019

Reactions to COVID-19: actions of nuclear medicine healthcare personnel in China

por Liu, Yan-Qing, Yang, Zhi, Lin, Yan-Song
Publicado 2020

Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration

por Sun, Yu-qing, Sun, Di, Zhang, Xin, Zhang, Ying-qiang, Lin, Yan-song
Publicado 2022

Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer

por Yang, Xue, Liang, Jun, Li, Tian-Jun, Yang, Ke, Liang, Dong-Quan, Yu, Zhuang, Lin, Yan-Song
Publicado 2015

Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis

por Zhao, Hao, Liu, Chun-Hao, Cao, Yue, Zhang, Li-Yang, Zhao, Ya, Liu, Yue-Wu, Liu, Hong-Feng, Lin, Yan-Song, Li, Xiao-Yi
Publicado 2022

An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy

por Zhao, Hao, Liu, Chun-Hao, Cao, Yue, Zhang, Li-Yang, Zhao, Ya, Zhang, Xin, Lin, Yan-Song, Xia, Yu, Liu, Yue-Wu, Liu, Hong-Feng, Li, Xiao-Yi
Publicado 2022